Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH7 | P40394 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1492442 | 0.93 | ALDH1A1 (0.40) | TSHRTRPM8ADH1BADH1CADH1A | |
| SCHEMBL22612189 | 0.91 | EPHX1 (0.41) | TSHRTRPM8ADH1BADH1CADH1A | |
| SCHEMBL3459170 | 0.85 | CA12 (0.32) | CA12CA1CA2CA9 | |
| SCHEMBL181351 | 0.76 | TSHR (0.43) | TSHRCA12CA1CA2ADH1B | |
| SCHEMBL578736 | 0.74 | TSHR (0.41) | TSHRCA12CA1CA2ADH1B | |
| SCHEMBL3461423 | 0.74 | — | — | |
| SCHEMBL1796804 | 0.74 | TSHR (0.41) | TSHRCA12CA1CA2ADH1B | |
| SCHEMBL28453204 | 0.73 | PLA2G1B (0.40) | TSHRADH1BADH1CADH1AADH7 | |
| SCHEMBL578855 | 0.72 | TSHR (0.39) | TSHRCA12CA1CA2ADH1B | |
| SCHEMBL27536406 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107540565-B | Preparation of N, N- (di) alkylaminoalkyl (meth) acrylamides or the corresponding esters and quaternary ammonium salts thereof | 赢创运营有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-107540565-A | The preparation of N, N (two) alkyl amino alkyl (methyl) acrylamide or corresponding ester and its quaternary ammonium salt | 赢创罗姆有限公司 | 2018-01-05 | — | — | CN | disclosed |
| US-8674133-B2 | Method for continuously producing alkylamino(meth)acrylamides | EVONIK RÖHM GMBH (DE) | 2014-03-18 | — | — | US | disclosed |
| US-20110313195-A1 | METHOD FOR CONTINUOUSLY PRODUCING ALKYLAMINO(METH)ACRYLAMIDES | EVONIK ROEHM GMBH (DE) | 2011-12-22 | — | — | US | disclosed |
| US-7723543-B2 | Method for the continuous production of alkyl amino acryl amides | EVONIK ROEHM GMBH (DE) | 2010-05-25 | — | — | US | disclosed |
| US-7586004-B2 | Method for continuously producing alkylamino(meth)acrylamides | ROEHM GMBH & CO. KG (DE) | 2009-09-08 | — | — | US | disclosed |
| US-20090149674-A1 | METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL AMINO ACRYL AMIDES | ROEHM GMBH (DE) | 2009-06-11 | — | — | US | disclosed |
| US-20070149811-A1 | Method for continuously producing alkylamino(meth)acrylamides | ROEHM GMBH & CO. KG (DE) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313195-A1 | METHOD FOR CONTINUOUSLY PRODUCING ALKYLAMINO(METH)ACRYLAMIDES | ACR, TET2, PAM | TSHR 2998/4885TRPM8 3671/4885CA12 2834/4885 |
| US-20090149674-A1 | METHOD FOR THE CONTINUOUS PRODUCTION OF ALKYL AMINO ACRYL AMIDES | ACR, NAAA, AANAT | TSHR 3540/4885TRPM8 4453/4885CA12 1746/4885 |
| US-20070149811-A1 | Method for continuously producing alkylamino(meth)acrylamides | ACR, MMAB, TET2 | TSHR 3088/4885TRPM8 4311/4885CA12 2524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.